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1. INTRODUCTION
In 2007, Dr. Atul Gawande led the World Health Organization 
(WHO) to investigate avoidable deaths in surgery, which resulted 
in the WHO Guidelines for Safe Surgery and the Surgical Safety 
Checklist and distribution of pulse oximeters to low- and middle-income 
countries (LMIC) [1]. As a result, many  Post-Anesthesia Care Units 
(PACUs) in austere settings assess respiratory status using pulse 
oximeters or qualitative clinical assessment when pulse oximetry 
is unavailable. However, repeated evidence that shows the detec-
tion of postsurgical complications, such as respiratory insufficiency 
(the focus of this study), may not be well communicated while using 
pulse oximeter monitoring [2–7]. Therefore, many LMIC hospitals 
may lack a reliable and continuous way of quantitatively monitoring 
ventilation in postoperative, non-intubated patients.
In the PACU, vigilant respiratory monitoring of all patients, espe-
cially those with a high risk of complications, is important to 
ensure proper patient care, as supported by the American Society 
of Anesthesiologists (ASA) [8]. This risk is elevated that pain man-
agement with opioids in the PACU can result in OIRD.
OIRD is a depression of respiratory rate (RR) below the normal 
12–20 breaths/min rate and may often go unnoticed by qualita-
tive respiratory monitoring techniques [9,10]. OIRD can result 
in oxygen desaturation, atelectasis, and worsening pain in at-risk 
patients. Patients with OIRD experience 55% longer hospital stays, 
47% higher care costs, 36% increased risk of 30‐day readmis-
sion, and 3.4 times higher risk of inpatient mortality compared to 
those with no opioid‐related adverse drug events [11]. Risk fac-
tors for developing OIRD include patients with obstructive sleep 
apnea, obese patients, the elderly, those with lung diseases and/
or sleep-related disorders, and patients who have had intravenous 
anesthetics, volatile agents, and opioids both intraoperatively and 
postoperatively [12]. OIRD may be diagnosed through respiratory 
monitoring and additional respiratory measures, such as minute 
ventilation (MV) and tidal volume (TV). MV and TV are reported 
on standard ventilators, but are absent from non-intubated 
patients [13]. In addition to limited respiratory monitoring tech-
nology in many hospitals, there is a lack of standardized diagnostic 
criteria in the literature, making OIRD diagnoses inconsistent and 
 arbitrary [2,9,14].
Respiratory monitoring may be improved using the respiratory 
volume monitor (RVM), which has recently been developed to 
provide real-time measurements of MV, TV, and RR, via a stan-
dardized set of bioimpedance thoracic electrodes in non- intubated 
patients. The RVM, shown in Figure 1, was approved by the 
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A B S T R AC T
This research aims to evaluate the use of the noninvasive respiratory volume monitor (RVM) compared to the standard of 
care (SOC) in the Post-Anesthesia Care Unit (PACU) of Kijabe Hospital, Kenya. The RVM provides real-time measurements 
for quantitative monitoring of non-intubated patients. Our evaluation was focused on the incidence of postoperative opioid-
induced respiratory depression (OIRD). The RVM cohort (N = 50) received quantitative OIRD assessment via the RVM, which 
included respiratory rate, minute ventilation, and tidal volume. The SOC cohort (N = 46) received qualitative OIRD assessment 
via patient monitoring with oxygenation measurements (SpO2) and physical examination. All diagnosed cases of OIRD were 
in the RVM cohort (9/50). In the RVM cohort, participants stayed longer in the PACU and required more frequent airway 
maneuvers and supplemental oxygen, compared to SOC (all p < 0.05). The SOC cohort may have had fewer diagnoses of OIRD 
due to the challenging task of distinguishing hypoventilation versus OIRD in the absence of quantitative data. To account for the 
higher OIRD risk with general anesthesia (GA), a subgroup analysis was performed for only participants who underwent GA, 
which showed similar results. The use of RVM for respiratory monitoring of OIRD may allow for more proactive care.
© 2020 The Authors. Published by Atlantis Press International B.V. 
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
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food and drug association (FDA) and has demonstrated accurate 
measurement of MV, TV, and RR [13,15–18]. The RVM can pro-
vide reproducible and comparable data to improve evaluation of 
respiratory status in various situations.
This research aims to evaluate the use of RVM compared to the stan-
dard of care (SOC) in the PACU of Kijabe Hospital, Kenya, specifi-
cally with the focus of OIRD diagnoses and related complications. The 
overall goal of this research is to identify potential strategies to improve 
respiratory monitoring and prevent postoperative complications.
2. MATERIALS AND METHODS
A prospective randomized study of an SOC cohort postsurgery com-
pared to an RVM cohort of similar postoperative participants was 
used. The RVM cohort received quantitative OIRD assessment via 
RVM, whereas the SOC cohort received qualitative OIRD assessment 
through physical examination. Postoperative respiratory function 
of participants and complications were compared between the two 
cohorts. Participants were observed in the PACU by PACU nurses.
2.1. Ethical Considerations
Ethical approval was obtained from the Research and Ethics 
Committee of the Kijabe Hospital. Written and informed consent 
was also obtained from each patient or family member, if the patient 
could not provide consent. Participants were explained the purpose 
of research, duration of participation by the subject, experimen-
tal procedure, and participant role. Participants were not required 
to give their names nor where they came from, and each partici-
pant was given a unique identification study number. No pictures, 
videotapes, or audiotapes were used during the study. No addi-
tional costs were incurred by the participants during the research. 
Participants were informed that they were free to withdraw from 
the study project at any point and no consequences would result.
2.2. Research Setting
The research was performed in the PACU of Africa Inland 
Church Kijabe Hospital, located in the rural Kiambu County, 
Kenya [20]. In 2014, Kijabe Hospital received two donated nonin-
vasive RVM ExSpiron machines from Respiratory Motion’s global 
outreach program aimed to improve patient care and education 
[19]. Kijabe Hospital was selected based on a long-term relation-
ship that Kijabe has with Vanderbilt University Medical Center 
through the Vanderbilt International Anesthesia (VIA) program. 
There is no financial relationship between Respiratory Motion 
and the authors of this paper.
2.3. Participants
Participants included non-intubated PACU patients aged 16–99 years 
who were at risk for OIRD (calculation explained below) and who 
underwent surgery under general anesthesia (GA) during daytime 
hours (from 8 AM to 5 PM, excluding weekends and public holi-
days). A power analysis projected a sample size of 96 participants 
would be appropriate for this study; therefore, 96 participants were 
enrolled randomly into both cohorts of the study. Demographics of 
participants are provided in the Supplementary Material.
2.4. Exclusion Criteria
The following patients were excluded: All intubated patients, chil-
dren aged 0–16 years, non-surgery patients, and patients undergo-
ing emergency or elective surgery during the night, weekends or on 
a public holiday. In both cohorts, any subject who had low O2 sat-
uration (below 94%) immediately postoperatively and did not have 
chronic obstructive pulmonary disease (COPD) was given oxygen 
via nasal cannula or facemask to keep O2 saturation above 94%. 
Also, any subject with upper airway obstruction had positioning 
improved by a jaw thrust and chin lift maneuver and left lateral posi-
tioning. Nasal and oral airways to help obstructions and suctioning 
to help secretions were also used to prevent respiratory insuffi-
ciency. Additionally, any subject who did not improve with these 
interventions, and was hemodynamically unstable, was intubated 
and transferred to the intensive care unit for further monitoring 
and mechanical ventilation.
2.5. SOC Cohort—Qualitative Assessment
The SOC for respiratory monitoring in the PACU consists of 
patient monitoring with oxygenation measurements (assessed 
by SpO2) and physical examination. The SOC cohort had RVM 
preoperatively to determine a baseline MV for each subject (cal-
culation explained below). Postoperatively, standard monitoring, 
observation, and documentation of vital signs were conducted with 
pulse oximeters and without RVM. Several variables that are fac-
tored into a PACU discharge score were measured for comparison. 
These variables included activity, breathing, circulation, level of 
consciousness, and pulse oximetry (oxygen saturation) [21]. After 
initial monitoring and satisfaction of PACU discharge criteria, par-
ticipants were discharged to the ward.
2.6. RVM Cohort—Quantitative Assessment
The same monitoring, observation, and documentation used in the 
SOC cohort were applied; however, the RVM cohort received RVM 
Figure 1 | ExSpiron respiratory volume monitor (Respiratory Motion, 
Inc., Waltham, MA, USA) [19].
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respiratory monitoring pre- and postoperatively in the PACU. 
The same variables and PACU discharge criteria used in the SOC 
cohort were applied.
2.7. Instrumentation
The Respiratory Motion ExSpiron RVM, a bioimpedance-based 
RVM, was used to collect digital respiratory traces from an 
Electrode PadSet placed on the thorax. As shown in Figure 2, one 
Electrode PadSet with three electrodes was placed along the ster-
num, the other on the level of the xiphoid process, and the other 
across the midaxillary line at the level of the xiphoid process. With 
the recommended electrode placement and calibration algorithms, 
the RVM measurements demonstrate a strong correlation with 
spirometric measurements (R > 0.96 ± 0.16, mean ± 95% confi-
dence interval for regular and erratic breathing) [16]. Electrode 
placements were determined by anatomical characteristics, and 
sensitive areas of participants were avoided. All PACU personnel 
were trained in proper use and interpretation of the RVM before 
the study.
3.  PROTOCOL AND OPERATIONAL  
DEFINITIONS
All participants were evaluated in PACU before and after surgery 
while in the supine position. Standard ASA monitoring was imple-
mented per PACU recommended practice (pulse oximetry, heart 
rate, and blood pressure monitoring). All data were documented via 
a data collection tool. For the detailed tool, see the Supplementary 
Material.
3.1. Preoperative (Same for Both Cohorts)
 • Estimated MV (MVesti) was calculated using: MVesti = TV × RR, 
where TV was calculated using 7 ml/kg.
 • Actual baseline MV (MVbase), TV, and RR were then measured 
using RVM for a period of 2 min of quiet breathing.
 • Percentage predicted MV (MVpred) is the ratio of MVbase and 
MVesti at baseline and was given as MVpred = (MVbase/MVesti) × 100.
 • At-risk classification = MV <80% of MVpred and as not at risk if 
their MV was >80% of MVpred.
Figure 2 | Standard PadSet placement. Noninvasive respiratory volume 
monitor [19].
3.2. Postoperative
 • RVM: OIRD = MV <40% of MVbase was observed and sustained 
for at least 2 min.
 • SOC: OIRD = RR below normal (12–20 breaths/min) sustained 
for >2 min.
3.3. Statistical Methods
Cohorts were compared using the Pearson Chi-square test and 
Wilcoxon test. A p value <0.05 was considered statistically signifi-
cant. Confidence intervals were generated using the Wilson score 
method.
4. RESULTS
OIRD was diagnosed in 9 of 50 participants in the RVM cohort 
(18%; 95% CI: 10%, 31%) and 0 of 46 participants in the SOC 
cohort (95% CI: 0%, 8%; Table 1). 
Comparing the SOC to the RVM cohort, participants in the 
RVM cohort had significantly more frequent OIRD diagnoses 
(p = 0.003), longer PACU stay duration (p = 0.035), and more fre-
quent administration of naloxone (p = 0.003), supplemental oxygen 
(p < 0.001), and airway maneuvers (p < 0.001; Table 1 and Figure 3). 
There was no evidence that admission status differed significantly 
by cohort (p = 0.110; Table 1).
Comparing participants diagnosed with OIRD to those who were 
not, those with OIRD received more airway maneuvers (p < 0.001), 
supplemental oxygen (p < 0.001), and total morphine equivalents 
(p = 0.024; Table 1). Those with OIRD were also more frequently 
administered naloxone (p < 0.001) and stayed longer in the PACU 
(p < 0.002; Figure 3 and Table 2).
Additionally, patients who received GA would be at a higher 
risk for developing OIRD due to the duel central nervous system 
depression primarily from GA and secondary from opioids 
[12,22]. Therefore, a secondary subgroup analysis was performed 
using only those patients that underwent GA. For this analysis, 
there were 27 participants in the RVM cohort and 11 participants 
in the SOC cohort. In this subgroup, OIRD was diagnosed in 
9 of 27 participants in the RVM cohort (33%; 95% CI: 19%, 52%) 
and 0 of 11 participants in the SOC cohort (95% CI: 0%, 26%; 
Table 3). Consistent with the complete sample analysis, patients 
in the RVM group had significantly more frequent OIRD diagno-
ses (p = 0.028), longer PACU stay duration (p = 0.035), and more 
frequent administration of naloxone (p = 0.042) and supplemen-
tal oxygen (p = 0.007; Table 3). However, in this subgroup, there 
was insufficient evidence of a difference PACU stay duration 
(p = 0.260), frequency of airway maneuvers (p < 0.140), or admis-
sion status (p = 0.711; Table 3).
5. DISCUSSION
The study aimed to evaluate the feasibility of using novel 
 monitoring techniques like the RVM in an austere setting, such 
as Kijabe Hospital, Kenya. This study demonstrates a difference in 
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Figure 3 | Length of stay in the Post-Anesthesia Care Unit (PACU) based 
on Opioid-induced respiratory depression (OIRD) diagnosis. Patients 
with evidence of OIRD stayed longer durations in the PACU.
postoperative diagnostic results, indicating that respiratory moni-
toring may be improved using such technology. Additionally, the 
costs incurred for such monitors may be justified by the reduction 
of additional laboratory testing (such as arterial blood gas measure-
ments), and maintenance is available free and available 24 h/day, 
7 days per week via telephone and online help platforms.
Indicated by the results, 18% (95% CI: 10%, 31%) of participants 
in the RVM cohort were diagnosed with OIRD, while none were 
diagnosed in the SOC cohort. The estimated incidence of OIRD 
diagnosis under SOC and RVM is 0.00 (95% CI: 0.00, 0.08) and 
0.18 (95% CI: 0.10, 0.31), respectively. The number needed to treat 
under RVM is 5.6 participants (95% CI: 3.2, 10.2). Additionally, 
although OIRD risk was somewhat greater in the RVM cohort 
despite randomization, 20% of participants in the SOC cohort were 
classified as at risk for OIRD; yet, there were still no OIRD diagno-
ses. This may indicate that some OIRD diagnoses were missed in 
the SOC cohort, and therefore, our results may present an underdi-
agnosis of OIRD. This may alternatively indicate that, despite ran-
domization, there truly were no cases of OIRD in the SOC cohort.
An alternative explanation would be that the RVM monitoring 
could have been too sensitive to respiratory depression, indicating 
an overdiagnosis. Previous studies were using similar OIRD cri-
teria as this study found an incidence of 5.6–22%, with an aver-
age rate of 11.5% [23]. Our incidence of 18% is above average, but 
not outside of the previously indicated range. If RVM monitoring 
were to overdiagnosis OIRD, this may limit the benefits by adding 
costs of care and extended stay for the patient. Considering the data 
presented in the study and previous work, we would hypothesize 




volume monitor Test statistic
N = 46 N = 50 1: Pearson test
2: Wilcoxon test
Opioid-induced respiratory depression diagnosis c 2 = 8.9 P1 = 0.003
 No 1.00 (46) 0.82 (41)
 Yes 0.00 (0) 0.18 (9)
Post-Anesthesia Care Unit duration (min) F = 4.6 P2 = 0.035
 25th percentile 46 50
 Median 50 62
 75% percentile 70 90
 X ± standard deviation 59 ± 29 71 ± 32
Naloxone administered c 2 = 8.9 P1 = 0.003
 No 1.00 (46) 0.82 (41)
 Yes 0.00 (0) 0.18 (9)
Airway maneuver required c 2 = 11 P1 = 0.001
 No 0.91 (42) 0.62 (31)
 Yes 0.09 (4) 0.38 (19)
O2 required c 2 = 12 P1 = 0.001
 No 0.71 (33) 0.36 (18)
 Yes 0.29 (13) 0.64 (32)
Admission status c 2 = 6 P1 = 0.110
 Discharged 0.20 (9) 0.12 (6)
 General ward 0.69 (32) 0.58 (29)
 HDU 0.09 (4) 0.28 (14)
 Intensive care unit 0.02 (1) 0.02 (1)
HDU, High dependency unit.
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that the SOC cohort being under diagnosis, rather than the RVM 
cohort being overdiagnosed.
One possible explanation for this underdiagnosis may be that 
in the SOC cohort, it was challenging to differentiate between 
 hypoventilation and OIRD diagnosis in the absence of  quantitative 
data. For example, qualitative measuring of a postoperative patient 
breathing at a below average rate would be classified as hypoven-
tilation. However, if the patient were to manifest signs of hyper-
carbia (no definitive qualitative test), the patient would meet 
Table 2 | Postsurgery comparison based on OIRD diagnosis
No OIRD diagnosis OIRD diagnosis Test statistic
Wald statisticN = 86 N = 9 1: Pearson test
2: Wilcoxon test
Weight (kg)
N = 95 F = 0.01 P2 = 0.94
c 2 = 0.2
P = 0.6532
 Lower quartile range 61 54
 Median 70 66
 Upper quartile range 80 95
 X ± SD 71 ± 14 72 ± 23
American Society of Anesthesiologists status (I–XI) c 2 = 1.8 P1 = 0.41 c 
2 = 0.22
N = 95 P = 0.8952
 I—Baseline 0.16 (14) 0.00 (0)
 II—Mild 0.50 (43) 0.56 (5)
 III—Severe 0.34 (29) 0.44 (4)
OIRD at risk (preoperative MV <80% of MVpred) c 2 = 9 P1 = 0.003 c 
2 = 4.53
N = 95 P = 0.0334
 No 0.79 (68) 0.33 (3)
 Yes 0.21 (18) 0.67 (6)
Respiratory volume monitor post c 2 = 8.9 P1 = 0.003 c 
2 = 0.08
N = 95 P = 0.7709
 No 0.52 (45) 0.00 (0)
 Yes 0.48 (41) 1.00 (9)
Total morphine equivalents F = 5.3 P2 = 0.024 c 
2 = 3.67
N = 94 P = 0.1596
 Lower quartile range 0.2 6
 Median 5 10
 Upper quartile range 14 20
 X ± SD 9 ± 14.5 13.7 ± 8.5
Post-Anesthesia Care Unit duration (min) F = 10 P2 = 0.002
N = 95
 Lower quartile range 45 75
 Median 60 90
 Upper quartile range 75 100
 X ± SD 62 ± 29 95 ± 35
Naloxone administered c 2 = 73 P1 < 0.001
N = 95
 No 0.99 (85) 0.11 (1)
 Yes 0.01 (1) 0.89 (8)
Airway maneuver required c 2 = 31 P1 < 0.001
N = 95
 No 0.84 (72) 0.00 (0)
 Yes 0.16 (14) 1.00 (9)
O2 required c 2 = 11 P1 < 0.001
N = 95
 No 0.58 (50) 0.00 (0)
 Yes 0.42 (36) 1.00 (9)
SpO2 F = 0.11 P2 = 0.74
N = 95
 Lower quartile range 0.94 0.95
 Median 0.95 0.96
 Upper quartile range 0.97 0.97
 X ± SD 0.95 ± 0.02 0.95 ± 0.03
OIRD, opioid-induced respiratory depression; SD, standard deviation.
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diagnostic criteria for OIRD and should be treated with naloxone. 
With this challenge, an SOC patient may be classified as hypoven-
tilating, yet not diagnosed with OIRD due to a lack of quantitative 
data. Furthermore, the elevated CO2 levels can lead to acidemia, 
which may lead to dysrhythmia. This dysrhythmia may not be 
detected given available electrocardiogram monitoring equipment, 
 unreliable  equipment (minimally functional equipment often gets 
donated [24]), and high patient to nurse ratios. By implementing 
RVM in clinical practice, the early indications of postoperative 
complications, such as OIRD, may be identified at a higher rate 
possibly resulting in appropriate treatment and improved patient 
outcomes.
Furthermore, the need for additional testing incurs additional costs 
and time for both the patient and hospital. Hypoventilation and 
acidemia are frequently assessed via arterial blood gas testing and 
may lead to dysrhythmia and electrolyte imbalance and right heart 
failure from pulmonary hypertension. This additional testing may 
not be required due to the real-time data of the RVM. This obser-
vation also contributes a possible financial benefit of increasing the 
amount of quantitative data that is available to providers by lower-
ing the amount of additional testing.
An additional challenge of RVM use is that CO2 monitoring 
requires a unimodal burden on visual attention, which may be 
tedious to a provider trying to monitor multiple patients and vital 
signs, especially with high patient to nurse ratios. Regardless of 
how well a visual display may be, visual attention will be limited 
by a high number of patients and tasks. Development of a com-
bined visual and auditory display for ventilation in devices such as 
the RVM and pulse oximeters may alleviate this strain. Ideally, this 
multisensory display would be present before the need of a warning 
alarm, notifying a dangerous change in vital signs and communi-
cating continuous monitoring.
As mentioned in the Introduction section, there is a lack of cohe-
siveness within the literature surrounding the effect of anesthe-
sia on respiratory mechanics. While OIRD is understood to be a 
decrease in RR, this definition only favors continuous, qualitative 
assessment without accounting for TV. In hospital units such as the 
PACU, respiratory monitoring via qualitative observations may not 
provide a sufficient level of care. Along with the suggestions in this 
paper in favor of quantitative RVM, the literature should also agree 
upon a stricter and clearer definition of conditions such as OIRD.
6. LIMITATIONS
This study was limited by the fact that it was unfunded and a first in 
kind at Kijabe Hospital. Therefore, dedicated research nurses were 
not available to record the interaction time of PACU nurses with 
participants. It is possible that a novel monitor may increase the 
time and attention the PACU personnel dedicated to these partici-
pants, which could explain the increased rates of OIRD detection. 
Additionally, Kenyan patients tend to be healthier than western 
patients (e.g., lower rates of hypertension, coronary artery disease, 
diabetes mellitus). While we do not believe this statistic to have a 
significant effect on our data, it is an important consideration when 
translating our data into diverse populations. Finally, regardless of 
our results, this is not a direct suggestion for hospitals to specifi-
cally invest in the ExSpiron RVM.
Table 3 | General anesthesia–only analysis postsurgery comparison based on cohort
Standard of care Respiratory volume monitor Test statistic
N = 11 N = 27 1: Pearson test
2: Wilcoxon test
Opioid-induced respiratory depression diagnosis c 2 = 4.8 P1 = 0.028
 No 1.00 (11) 0.67 (18)
 Yes 0.00 (0) 0.33 (9)
Post-Anesthesia Care Unit duration (min) F = 1.3 P2 = 0.26
 25th Percentile 52 60
 Median 60 75
 75% Percentile 75 90
 X ± standard deviation 65 ± 38 77 ± 30
Naloxone administered c 2 = 4.1 P1 = 0.042
 No 1.00 (11) 0.70 (19)
 Yes 0.00 (0) 0.3 (8)
Airway maneuver required c 2 = 2.2 P1 = 0.14
 No 0.64 (7) 0.37 (10)
 Yes 0.36 (4) 0.63 (17)
O2 required c 2 = 7.4 P1 = 0.007
 No 0.64 (7) 0.19 (5)
 Yes 0.36 (4) 0.81 (22)
Admission status c 2 = 1.4 P1 = 0.71
 Discharged 0.09 (1) 0.11 (3)
 General ward 0.55 (6) 0.41 (11)
 HDC 0.27 (3) 0.44 (12)
 Intensive care unit 0.09 (1) 0.04 (1)
HDU, High dependency unit.
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7. CONCLUSION
Our evaluation of using a noninvasive RVM in an austere hospital 
setting indicated an increase in data available to assist respiratory 
monitoring and patient diagnosis. The RVM provided quantitative 
data to be used by providers for their consideration of a postop-
erative complication diagnosis. Specifically, our results showed a 
higher rate of OIRD diagnosis in the RVM group. The SOC cohort 
may have had fewer diagnoses of OIRD due to the challenging 
task of distinguishing hypoventilation versus OIRD. Therefore, the 
difference in respiratory monitoring via the noninvasive, quanti-
tative RVM may be the benefit of subtle diagnoses and interven-
tion. The benefit to subtle diagnoses is specifically significant for 
LMIC where overall care is improving, through the generous work 
of donations, charitable groups, and missionary clinicians, and 
therefore, healthcare needs to now be more sensitive to decreasing 
morbidity, rather than just mortality.
More work must be done with the goals of developing clear diag-
nostic criteria for OIRD; a cost-effective, quantitative ventilation 
monitor for non-intubated patients; and an auditory display for 
ventilation devices (such as the RVM and pulse oximeter) with 
continuous monitoring to signal a maladaptive change before a 
warning alarm or need for intervention. Opportunities to imple-
ment proactive care into hospital workflows may improve patient 
care, monitoring, and safety.
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